Anzeige
Mehr »
Mittwoch, 10.12.2025 - Börsentäglich über 12.000 News
Diese Biotech-News am 11. Dezember könnte 2026 komplett verändern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QKU8 | ISIN: US09076D1019 | Ticker-Symbol:
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
AI MAVERICK INTEL INC Chart 1 Jahr
5-Tage-Chart
AI MAVERICK INTEL INC 5-Tage-Chart

Aktuelle News zur AI MAVERICK INTEL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.10.AI Maverick Intel, Inc. Announces New Trading Symbol "AIMV" Effective Oct. 20, 2025220NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- via IBN - AI Maverick Intel Inc. (OTC: AIMV), a technology-driven innovator focused on redefining how businesses acquire and engage customers through artificial...
► Artikel lesen
12.08.AI Maverick Intel, Inc.: AI Maverick Intel Provides Corporate Update349NEW YORK CITY, NEW YORK / ACCESS Newswire / August 12, 2025 / AI Maverick Intel Inc. (OTCID:BINP), a technology-driven innovator focused on redefining how businesses acquire and engage customers through...
► Artikel lesen
30.07.AI Maverick Intel, Inc.: IBN Initiates Coverage of AI Maverick Intel Inc.416NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / AI Maverick Intel Inc. (OTC:BINP), a technology-forward company focused on transforming how businesses acquire and engage customers through...
► Artikel lesen
17.07.AI Maverick Intel, Inc.: AI Maverick Launches Enhanced Prospecting Platform to Deliver Human Like Outreach - No SDR Team Required313NEW YORK CITY, NEW YORK / ACCESS Newswire / July 17, 2025 / AI Maverick Intel, Inc. (OTCID:BINP) ("AI Maverick" or the "Company") today announces the full rollout of its next-generation prospecting...
► Artikel lesen
29.05.Bionoid Pharma, Inc. Confirms Name Change to AI Maverick Intel, Inc. Following Delaware Approval1.390Company Has Initiated FINRA Process to Complete Rebranding and Ticker Update NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bionoid Pharma, Inc. (OTC PINK:BINP) ("Bionoid" or the "Company") is...
► Artikel lesen
16.05.Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation689NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation...
► Artikel lesen
11.04.Bionoid Pharma, Inc.: Bionoid Pharma Announces Completion of 2024 Financial Audit334NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for...
► Artikel lesen
09.04.Bionoid Pharma, Inc.: Bionoid Pharma Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements321NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its...
► Artikel lesen
AI MAVERICK INTEL Aktie jetzt für 0€ handeln
19.03.Bionoid Pharma, Inc.: Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity306NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture...
► Artikel lesen
13.03.Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm305NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its financial audits for the fiscal years 2022...
► Artikel lesen
14.01.Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025277NEW YORK CITY, NEW YORK / ACCESSWIRE / January 14, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The...
► Artikel lesen
08.01.Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.282NEW YORK, NY / ACCESSWIRE / January 8, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter...
► Artikel lesen
12.12.24Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.333NEW YORK, NY / ACCESSWIRE / December 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd....
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1